Top compounds associated with response to C19orf70


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.078 0.03
mRNA ruxolitinib CTRPv2 pan-cancer AAC -0.075 0.03
mRNA Camptothecin GDSC1000 pan-cancer AAC -0.071 0.03
mRNA GW-405833 CTRPv2 pan-cancer AAC -0.074 0.03
mRNA Gefitinib CTRPv2 pan-cancer AAC -0.079 0.03
mRNA NSC632839 CTRPv2 pan-cancer AAC -0.073 0.03
mRNA indisulam CTRPv2 pan-cancer AAC -0.069 0.03
mRNA JQ-1:vorinostat (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.072 0.03
mRNA Teniposide CTRPv2 pan-cancer AAC -0.086 0.03
mRNA Bleomycin CTRPv2 pan-cancer AAC -0.081 0.03
Download CSV